Adaptimmune Snags FDA Nod For TCR Therapy Tecelra

 
• By Alaric DeArment
Adaptimmune received accelerated approval from the FDA for its TCR therapy, Tecelra • Source: Shutterstock

More from New Products

More from Scrip